Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization.
Beech C, Wilcock DM, Moore KH, Rowe L, Mahlow J, Jedrzkiewicz J, Cleary AS, Lomo L, Ruano AL, Gering M, Bradshaw D, Maughan M, Tran P, Davis R, Affolter K, Albertson DJ, Adelhardt P, Kim J, Coleman JF, Deftereos G, Gulbahce EH, Sirohi D.
Beech C, et al. Among authors: gulbahce eh.
Appl Immunohistochem Mol Morphol. 2025 Mar 1;33(2):91-102. doi: 10.1097/PAI.0000000000001247. Epub 2025 Jan 27.
Appl Immunohistochem Mol Morphol. 2025.
PMID: 39866038